@article {:2007-02-24:1173-8324:23,
	title = "Tibotec Pharmaceuticals' protease inhibitor darunavir [PREZISTA] has received conditional marketing authorisation from the European Commission",
	journal = "Inpharma",
	volume = "1",
	year = "2007-02-24",
	abstract = "",
	pages = "23-23(1)",
	url = "http://www.ingentaconnect.com/content/adis/inp/2007/00000001/00001576/art00073"
}